Curocell logo

Curocell

Fight against hopelessness

26 employees · est. 2016 · Daejeon, Korea South

VS
NexImmune, Inc. logo

NexImmune, Inc.

NexImmune, Directing T cell function to restore natural immunity

32 employees · est. 2011 · Gaithersburg, United States

NexImmune, Inc. is the older company (2016 vs 2011).

Side-by-Side Comparison

Curocell NexImmune, Inc.
Founded
2016 2011 older
Headquarters
Daejeon, Korea South Gaithersburg, United States
Employees
26 32
Industry
Biopharma, Biotechnology Biopharma, Biotechnology, Health and Wellness
Funding Stage
Series Unknown Post Ipo Equity
Total Funding
$80.00B $87.44M
Funding Rounds
4 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Curocell, Cell Therapy, CAR-T Therapies, Cancer Treatment, Immunotherapy, Blood Cancers, Solid Cancers, Programmed T Cell, Immunotherapy Technology, Immune System, T Cell Modifying Technology, Immune Suppression, Efficacy, Oncology Immunotherapy, T Cell Immunotherapies, Cancer Treatment, Clinical Stage, Proprietary Technology, AIM Technology, Oncology, Autoimmune Disorders, Pharmaceutical Company, Immuno-therapeutics, Artificial Immune Modulation, Nanoparticles, Acute Myeloid Leukemia, Multiple Myeloma
Website
curocellbtx.com neximmune.com
Curocell logo

About Curocell

Curocell, founded in 2016 and headquartered in South Korea, is a cutting-edge company in the biopharma and biotechnology sectors. The company's slogan, "Fight against hopelessness," underscores its mission to revolutionize cancer treatment through the development of innovative CAR-T therapies. Cur...

NexImmune, Inc. logo

About NexImmune, Inc.

NexImmune, Inc. is a publicly traded, clinical stage biotechnology company founded in 2011 and is making strides in the development of T cell immunotherapies through its propriety Artificial Immune Modulation (AIM™) technology. The company is focused on addressing unmet medical needs in oncology, sp...

We will tell you when either one moves

BounceWatch watches Curocell and NexImmune, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Curocell and NexImmune, Inc. — by email.

Frequently Asked Questions

Curocell — Fight against hopelessness. NexImmune, Inc. — NexImmune, Directing T cell function to restore natural immunity. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Curocell has raised $80.00B while NexImmune, Inc. has raised $87.44M.
Curocell and NexImmune, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Curocell with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Curocell on 12 Sep 2024, and NexImmune, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy